Literature DB >> 6607030

Multiply resistant viridans streptococci: susceptibility to beta-lactam antibiotics and comparison of penicillin-binding protein patterns.

B F Farber, G M Eliopoulos, J I Ward, K L Ruoff, V Syriopoulou, R C Moellering.   

Abstract

A unique group of viridans streptococci has been found in South Africa. These organisms were isolated in close temporal and physical proximity to the isolation of penicillin-resistant pneumococci. The strains were resistant to penicillin, oxacillin, the cephalosporins (all generations), piperacillin, azlocillin, and mezlocillin but were susceptible to vancomycin. Penicillin-binding proteins of two penicillin-resistant South African strains of Streptococcus mitis differed markedly from those of two penicillin-susceptible strains but were identical to those seen in a penicillin-resistant strain isolated in Boston. Although both susceptible strains were identified as S. mitis with identical biochemical profiles, their penicillin-binding protein patterns differed from each other. This finding may have significance with regard to the need for additional taxonomic classification of the viridans streptococci.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6607030      PMCID: PMC185928          DOI: 10.1128/AAC.24.5.702

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Emergence of multiply resistant pneumococci.

Authors:  M R Jacobs; H J Koornhof; R M Robins-Browne; C M Stevenson; Z A Vermaak; I Freiman; G B Miller; M A Witcomb; M Isaäcson; J I Ward; R Austrian
Journal:  N Engl J Med       Date:  1978-10-05       Impact factor: 91.245

2.  Identification of viridans streptococci isolated from clinical specimens.

Authors:  K L Ruoff; L J Kunz
Journal:  J Clin Microbiol       Date:  1982-05       Impact factor: 5.948

3.  Infective endocarditis--an evolving disease. A review of endocarditis at the Columbia-Presbyterian Medical Center, 1968-1973.

Authors:  G J Garvey; H C Neu
Journal:  Medicine (Baltimore)       Date:  1978-03       Impact factor: 1.889

4.  Rapid detection of ampicillin-resistant Haemophilus influenzae and their susceptibility to sixteen antibiotics.

Authors:  R B Kammer; D A Preston; J R Turner; L C Hawley
Journal:  Antimicrob Agents Chemother       Date:  1975-07       Impact factor: 5.191

5.  Penicillin-binding proteins of multiply antibiotic-resistant South African strains of Streptococcus pneumoniae.

Authors:  S Zighelboim; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

6.  Susceptibility of pneumococci to 14 beta-lactam agents: comparison of strains resistant, intermediate-resistant, and susceptible to penicillin.

Authors:  J I Ward; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

7.  Resistance to beta-lactam antibiotics in Streptococcus faecium.

Authors:  G M Eliopoulos; C Wennersten; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

8.  Multiple changes of penicillin-binding proteins in penicillin-resistant clinical isolates of Streptococcus pneumoniae.

Authors:  R Hakenbeck; M Tarpay; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

Review 9.  Penicillin-binding proteins in bacteria.

Authors:  A Tomasz
Journal:  Ann Intern Med       Date:  1982-04       Impact factor: 25.391

10.  Antibiotic susceptibilities of streptococci from the mouth and blood of patients treated with penicillin or lincomycin and clindamycin.

Authors:  I Phillips; C Warren; J M Harrison; P Sharples; L C Ball; M T Parker
Journal:  J Med Microbiol       Date:  1976-11       Impact factor: 2.472

View more
  20 in total

1.  Brain abscess due to Wolinella recta and Streptococcus intermedius.

Authors:  T J Marrie; E Kerr
Journal:  Can J Infect Dis       Date:  1990

Review 2.  Modification of penicillin-binding proteins as mechanisms of beta-lactam resistance.

Authors:  F Malouin; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

3.  Multiply resistant Streptococcus mitis isolated from conjunctival exudate of newborns.

Authors:  S Kontiainen; A Sivonen
Journal:  Eur J Clin Microbiol       Date:  1987-02       Impact factor: 3.267

4.  Endocarditis Caused by Highly Penicillin-Resistant Viridans Group Streptococci: Still Room for Vancomycin-Based Regimens.

Authors:  Juan M Pericàs; Ruvandhi Nathavitharana; Cristina Garcia-de-la-Mària; Carles Falces; Juan Ambrosioni; Manel Almela; Javier García-González; Eduard Quintana; Francesc Marco; Asunción Moreno; Arnold S Bayer; José M Miró; Adolf W Karchmer
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

5.  Mycotic Aneurysm Caused by Streptococcus constellatus subsp. constellatus.

Authors:  Wen-Chu Chiang; Jui-Chang Tsai; Shey-Ying Chen; Chiung-Yuan Hsu; Chen-Tu Wu; Lee-Jene Teng; Po-Ren Hsueh
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

6.  Chromosomally mediated high-level gentamicin resistance in Streptococcus mitis.

Authors:  A Kaufhold; E Potgieter
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

7.  In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures.

Authors:  E Potgieter; M Carmichael; H J Koornhof; L J Chalkley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

8.  Resistance to penicillin-streptomycin synergy among clinical isolates of viridans streptococci.

Authors:  B F Farber; G M Eliopoulos; J I Ward; K Ruoff; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1983-12       Impact factor: 5.191

9.  In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.

Authors:  G M Eliopoulos; A Gardella; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

Review 10.  Cephalosporins--cefotaxime 10 years later, a major drug with continued use.

Authors:  H C Neu
Journal:  Infection       Date:  1991       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.